14 employees
Highlight Therapeutics is a clinical-stage biopharmaceutical company.
2010
$27M
from 3 investors over 3 rounds
BiOncotech Therapeutics raised $27M on February 4, 2021
Investors: COLUMBUS VENTURE PARTNERS,S.G.E.I.C., S.A.U., Advent Life Sciences and CDTI, Centre for the Development of Industrial Technology